HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial.

AbstractUNLABELLED:
No proven treatment exists for nonalcoholic fatty liver disease (NAFLD) in children and adolescents. We sought to determine the efficacy of lifestyle intervention with or without antioxidant therapy in pediatric NAFLD. A total of 53 patients (age 5.7-18.8 years, 37 boys) were included. Lifestyle intervention consisting of a diet tailored to the patient's calorie needs, and increased physical activity was prescribed in all. Patients were concomitantly randomized to alpha-tocopherol 600 IU/day plus ascorbic acid 500 mg/day (n = 25) or placebo (n = 28), and treated for 24 months. The study was an extension of a previous study aimed at evaluating the effect of 12-month lifestyle intervention and antioxidant therapy on serum levels of aminotransferases. The primary end point of the present study was change in liver histology on repeated biopsy at 24 months. Secondary end points were changes in body weight, liver enzymes, and insulin sensitivity indices on 2-hour oral glucose tolerance test. The amount of weight lost at 24 months was similar in the placebo and antioxidant groups (-4.75 [range, -16-4.0] versus -5.5 [range, -12.2-0.4] kg, respectively, P = 0.9). A significant improvement occurred in the grade of steatosis, lobular inflammation, and hepatocyte ballooning, and in the NAFLD activity score in both groups. Levels of aminotransferases, triglycerides, cholesterol, fasting glucose, and insulin, and insulin sensitivity indices improved significantly as well. The improvement in all these parameters was not significantly different between the two groups.
CONCLUSION:
Lifestyle intervention with diet and increased physical activity induces weight loss and is associated with a significant improvement in liver histology and laboratory abnormalities in pediatric NAFLD. Alpha-tocopherol plus ascorbic acid does not seem to increase the efficacy of lifestyle intervention alone.
AuthorsValerio Nobili, Melania Manco, Rita Devito, Vincenzo Di Ciommo, Donatella Comparcola, Maria Rita Sartorelli, Fiorella Piemonte, Matilde Marcellini, Paul Angulo
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 48 Issue 1 Pg. 119-28 (Jul 2008) ISSN: 1527-3350 [Electronic] United States
PMID18537181 (Publication Type: Journal Article, Randomized Controlled Trial)
Chemical References
  • Antioxidants
  • Blood Glucose
  • Insulin
  • Lipids
  • Transaminases
  • alpha-Tocopherol
  • Ascorbic Acid
Topics
  • Adolescent
  • Antioxidants (therapeutic use)
  • Ascorbic Acid (therapeutic use)
  • Blood Glucose (analysis)
  • Body Weight
  • Child
  • Diet, Reducing
  • Double-Blind Method
  • Exercise Therapy
  • Fasting (blood)
  • Fatty Liver (blood, pathology, physiopathology, therapy)
  • Female
  • Humans
  • Insulin (blood)
  • Insulin Resistance
  • Life Style
  • Lipids (blood)
  • Liver (pathology)
  • Male
  • Time Factors
  • Transaminases (blood)
  • Treatment Outcome
  • alpha-Tocopherol (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: